Citation Impact
Citing Papers
Agar and broth dilution methods to determine the minimal inhibitory concentration (MIC) of antimicrobial substances
2008 Standout
Development of a selective and sensitive polymerase chain reaction assay for the detection ofMycoplasma pirum
1993 StandoutNobel
Levofloxacin: a therapeutic review
1998
Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults
2007 Standout
Natural products: An evolving role in future drug discovery
2011 Standout
A comparison of pefloxacin/metronidazole and doxycycline/metronidazole in the treatment of laparoscopically confirmed acute pelvic inflammatory disease
1993
Oxazolidinone antibiotics
2001
In Vitro Activity of Tigecycline against Isolates from Patients Enrolled in Phase 3 Clinical Trials of Treatment for Complicated Skin and Skin‐Structure Infections and Complicated Intra‐Abdominal Infections
2005
Steady-state serum and intrapulmonary pharmacokinetics and pharmacodynamics of tigecycline
2005
Tigecycline: First of a New Class of Antimicrobial Agents
2006
Individualised antibiotic dosing for patients who are critically ill: challenges and potential solutions
2014 Standout
Ecology of prokaryotic viruses
2003 Standout
Optical control of antibacterial activity
2013 StandoutNobel
Ureaplasma urealyticum urease genes; use of a UGA tryptophan codon
1990
Metabolism and excretion kinetics of 14C-labeled and non-labeled difloxacin in pigs after oral administration, and antimicrobial activity of manure containing difloxacin and its metabolites
2009
Telithromycin
2004
Purification of urease from Ureaplasma urealyticum
1987
Glycylcyclines: third-generation tetracycline antibiotics
2001
Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America
2008 Standout
Mechanism of tetracycline resistance by ribosomal protection protein Tet(O)
2013 StandoutNobel
Bad Bugs Need Drugs: An Update on the Development Pipeline from the Antimicrobial Availability Task Force of the Infectious Diseases Society of America
2006 Standout
Natural products to drugs: natural product-derived compounds in clinical trials
2008 Standout
The chemistry and biological profile of trovafloxacin
1997
Antimicrobial activity and spectrum of the new glycylcycline, GAR-936 tested against 1,203 recent clinical bacterial isolates
2000
A standardized bacterial taxonomy based on genome phylogeny substantially revises the tree of life
2018 Standout
Newer antibacterial drugs for a new century
2010
Catabolism in Mollicutes
1992
The Glycylcyclines
2004
Characterization of a majorMycoplasma penetranslipoprotein and of its gene
1995 StandoutNobel
Oxazolidinones: activity, mode of action, and mechanism of resistance
2004 Standout
A Brief History of the Antibiotic Era: Lessons Learned and Challenges for the Future
2010 Standout
Outer-membrane vesicles from Gram-negative bacteria: biogenesis and functions
2015 Standout
Fungi, Mycobacteria, Zoonotic and Other Organisms in Prosthetic Joint Infection
2006
Sexually transmitted diseases treatment guidelines
2003 Standout
New developments in tetracycline antibiotics: glycylcyclines and tetracycline efflux pump inhibitors
2002
Atypical pneumonia in the Nordic countries: aetiology and clinical results of a trial comparing fleroxacin and doxycycline. Nordic Atypical Pneumonia Study Group
1997
A plastid organelle as a drug target in apicomplexan parasites
1997 StandoutNature
A random sequencing approach for placing markers on the physical map ofMycoplasma genitalium
1991
Subtraction hybridisation and shot-gun sequencing: a new approach to identify symbiotic loci
1994 StandoutNobel
Newly documented antimicrobial activity of quinolones
1991
A Common Mechanism of Cellular Death Induced by Bactericidal Antibiotics
2007 Standout
Nucleotide sequence of the P1 attachment-protein gene of Mycoplasma pneumoniae
1988
How antibiotics kill bacteria: from targets to networks
2010 Standout
Tigecycline: A New Glycylcycline for Treatment of Serious Infections
2005
Amplification of 16S rRNA genes from culturable and nonculturable Mollicutes
1991 Standout
Quinolone Antimicrobial Agents
1992
Acinetobacter baumannii : Emergence of a Successful Pathogen
2008 Standout
In Vitro and In Vivo Antibacterial Activities of a Novel Glycylcycline, the 9- t -Butylglycylamido Derivative of Minocycline (GAR-936)
1999
Genetic and Antigenic Distinction of Mycoplasma pirum from Other Mycoplasmas with Specialized Tip Structures
1988
Microbial carbonate precipitation in construction materials: A review
2009 Standout
The proline-rich P65 protein of Mycoplasma pneumoniae is a component of the Triton X-100-insoluble fraction and exhibits size polymorphism in the strains M129 and FH
1995
Microbial ureases: significance, regulation, and molecular characterization
1989 Standout
Antibiotics and Bacterial Resistance in the 21st Century
2014 Standout
Mechanisms of DNA Excision Repair
1994 StandoutScienceNobel
Tetracycline resistance determinants in streptococcal species isolated from the bovine mammary gland
1991
Molecular characterization of the P1-like adhesin gene from Mycoplasma pirum
1994 StandoutNobel
Gentlemen Dissenters: The Social and Political Meanings of Rational Dissent in the 1770s and 1780s
1985
Antimicrobial Resistance in Neisseria gonorrhoeae in the 21st Century: Past, Evolution, and Future
2014 Standout
Sampling the Antibiotic Resistome
2006 StandoutScience
Ureaplasma urealyticum intrauterine infection: role in prematurity and disease in newborns
1993
Purification and characterization of Mycoplasma penetrans Ca2+/Mg2+-dependent endonuclease
1997 StandoutNobel
Organization of Ureaplasma urealyticum urease gene cluster and expression in a suppressor strain of Escherichia coli
1996 StandoutNobel
Conjugal transfer of transposon Tn916 from Streptococcus faecalis to Mycoplasma hominis
1987
Fluorine in medicinal chemistry: Recent therapeutic applications of fluorinated small molecules
2006 Standout
Tigecycline: A new glycylcycline antimicrobial agent
2006
Common Deoxyribonucleic Acid Sequences in Mycoplasma genitalium and Mycoplasma pneumoniae Genomes
1986
Tetracycline Antibiotics: Mode of Action, Applications, Molecular Biology, and Epidemiology of Bacterial Resistance
2001 Standout
Molecular biology of microbial ureases
1995 Standout
Role ofMycoplasma penetransEndonuclease P40 as a Potential Pathogenic Determinant
1999 StandoutNobel
The Crisis in Antibiotic Resistance
1992 StandoutScience
Contribution of Topoisomerase IV Mutation to Quinolone Resistance in Mycoplasma genitalium
2013
Ciprofloxacin–Photoswitch Conjugates: A Facile Strategy for Photopharmacology
2015 StandoutNobel
Regions of Mycoplasma pneumoniae cytadhesin P1 structural gene exist as multiple copies
1988
Virulence of ureaplasmal urease for mice
1991
Phytoplasma: Phytopathogenic Mollicutes
2000 Standout
Tigecycline MIC Testing by Broth Dilution Requires Use of Fresh Medium or Addition of the Biocatalytic Oxygen-Reducing Reagent Oxyrase To Standardize the Test Method
2005
Molecular Biology and Pathogenicity of Mycoplasmas
1998 Standout
Ureaplasma Urealyticum Upper Urinary Tract Infection: Persistence and Pathogenicity in a Canine Model
1989
The Sources of Social Power
1986 Standout
The Candidatus Liberibacter–Host Interface: Insights into Pathogenesis Mechanisms and Disease Control
2017 Standout
Prosthetic Joint Infection
2014 Standout
Growth inhibition of Ureaplasma urealyticum by the proton pump inhibitor lansoprazole: direct attribution to inhibition by lansoprazole of urease activity and urea-induced ATP synthesis in U. urealyticum
1995
Trovafloxacin is active against Toxoplasma gondii
1996
Community-Associated Methicillin-ResistantStaphylococcus aureus: Epidemiology and Clinical Consequences of an Emerging Epidemic
2010 Standout
Antiparasitic agents produced by microorganisms
2004 StandoutNobel
In Vivo Pharmacodynamic Activities of Two Glycylcyclines (GAR-936 and WAY 152,288) against Various Gram-Positive and Gram-Negative Bacteria
2000
Immunoblot analyses of chimpanzee sera after infection and after immunization and challenge with Mycoplasma pneumoniae
1994
Characteristics of Ureaplasma urealyticum urease
1988
Role of mycoplasma infection in the cytopathic effect induced by human immunodeficiency virus type 1 in infected cell lines
1992 StandoutNobel
Republicanism, popular constitutionalism and the radical platform in early nineteenth‐century England
1981
Diagnostic Virology Using Electron Microscopic Techniques
1982
Molecular biology and genetics of mycoplasmas (Mollicutes)
1985
Dissemination of the tetM tetracycline resistance determinant to Ureaplasma urealyticum
1986
Prescribed drugs containing nitrogen heterocycles: an overview
2020 Standout
Levofloxacin and Sparfloxacin: New Quinolone Antibiotics
1998
The Talk and Back Talk of Collective Action: A Dialogic Analysis of Repertoires of Discourse among Nineteenth‐Century English Cotton Spinners
1999 Standout
Works of F D Cartwright being referenced
Mycoplasma orale infection affects K+ and Cl− currents in the HSG salivary gland cell line
1996
Morphology, morphometry and electron microscopy of HeLa cells infected with bovine Mycoplasma
1976
Susceptibilities of Mycoplasma hominis, Mycoplasma pneumoniae, and Ureaplasma urealyticum to new glycylcyclines in comparison with those to older tetracyclines
1994
Susceptibilities of Mycoplasma pneumoniae, Mycoplasma hominis, and Ureaplasma urealyticum to a new quinolone, trovafloxacin (CP-99,219)
1996
Susceptibilities of Mycoplasma hominis, M. pneumoniae , and Ureaplasma urealyticum to GAR-936, Dalfopristin, Dirithromycin, Evernimicin, Gatifloxacin, Linezolid, Moxifloxacin, Quinupristin-Dalfopristin, and Telithromycin Compared to Their Susceptibilities to Reference Macrolides, Tetracyclines, and Quinolones
2001
Agar dilution method for determination of antibiotic susceptibility of Ureaplasma urealyticum
1986
The life and correspondence of Major Cartwright
1969
Sparfloxacin Selects Gyrase Mutations in First-Step Mycoplasma hominis Mutants, whereas Ofloxacin Selects Topoisonmerase IV Mutations
1999
Susceptibilities of genital mycoplasmas to the newer quinolones as determined by the agar dilution method
1989
Effect of Urea Concentration on Growth of Ureaplasma urealyticum (T-Strain Mycoplasma)
1977
Susceptibility of Mycoplasma pneumoniae to several new quinolones, tetracycline, and erythromycin
1991
The principal protein antigens of isolates of Mycoplasma pneumoniae as measured by levels of immunoglobulin G in human serum are stable in strains collected over a 10-year period
1987
Immunoblotting for determination of the antigenic specificities of antibodies to the Mycoplasmatales.
1984